Home High Blood Pressure One shot every 6 months may treat high blood pressure effectively

One shot every 6 months may treat high blood pressure effectively

Credit: Unsplash+

High blood pressure, also known as hypertension, affects millions of people across the world. It is often called a “silent” condition because many people do not feel any symptoms, even when their blood pressure is dangerously high.

Over time, however, uncontrolled high blood pressure can quietly damage the body. It increases the risk of heart attacks, strokes, kidney disease, heart failure, and even early death. For this reason, keeping blood pressure under control is one of the most important steps in protecting long-term health.

Most people with high blood pressure are prescribed daily medication. These pills help relax blood vessels, reduce fluid buildup, or block hormones that raise blood pressure. When taken regularly, they can be very effective.

However, remembering to take medicine every single day can be difficult. Some people forget. Others stop taking their medication because of side effects or because they feel fine and believe they no longer need it. Missing doses can allow blood pressure to rise again, increasing the risk of serious health problems.

Now, researchers are testing a new treatment that could make managing high blood pressure much simpler. The drug is called zilebesiran. Instead of taking a pill every day, patients may only need one injection that works for up to six months. A team of scientists, including researchers from the University of Edinburgh, has been studying this new approach.

In early studies carried out in the United Kingdom, people who received a single injection of zilebesiran experienced significant reductions in their blood pressure. A 200 milligram dose lowered systolic blood pressure—the top number in a blood pressure reading—by more than 10 millimeters of mercury.

Higher doses had even stronger effects. The largest tested dose of 800 milligrams reduced systolic pressure by more than 20 millimeters of mercury. Such reductions are considered meaningful and could greatly lower the risk of heart attacks and strokes if maintained over time.

Zilebesiran works in a different way from many traditional blood pressure medications. It targets a hormone system in the body that controls blood vessel tightening. One important hormone in this system is called angiotensin.

When angiotensin levels rise, blood vessels narrow, and blood pressure goes up. Zilebesiran acts in the liver to block the production of a protein called angiotensinogen, which is needed to create angiotensin. Without enough angiotensin, blood vessels stay more relaxed, and blood pressure falls.

The early clinical trial involved 107 adults with high blood pressure. Of these participants, 80 received zilebesiran, while the others were given a placebo, which is an inactive treatment used for comparison. Those who received the real drug showed clear improvements in their blood pressure levels compared to those who did not.

Although the early results are promising, scientists caution that more research is needed. Larger studies over longer periods will help determine whether the drug remains safe and effective in different groups of patients. It is also important to monitor for any possible side effects that may appear over time.

Professor David Webb from the University of Edinburgh described the development as a major step forward in high blood pressure treatment. He noted that it has been 17 years since a completely new type of blood pressure drug was introduced.

If zilebesiran proves successful in future trials, it could help many patients stick to their treatment plans more easily. For some people, receiving two injections a year may be far simpler than remembering to take daily pills.

High blood pressure remains one of the leading causes of preventable illness and death worldwide. New treatment options that improve convenience and long-term control could have a large impact on public health.

While more testing is still required, zilebesiran represents a hopeful step toward better and more practical care for people living with hypertension.

The findings from this research were published in the New England Journal of Medicine. They mark an important new chapter in the search for safer, longer-lasting treatments to help people manage high blood pressure and protect their hearts.

If you care about high blood pressure, please read studies about breakfast for better blood pressure management, and the gut feeling that lowers blood pressure.

For more health information, please see recent studies about how the dash diet helps lower blood pressure, and how to eat your way to healthy blood pressure.

Copyright © 2026 Knowridge Science Report. All rights reserved.